--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q334.000K / 0.000--
--2024/Q213.000K / 0.000--
--2024/Q10.000 / 0.000--
MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
LYEL Lyell Immunopharma
- 0.613
- -0.028-4.41%
Close Dec 20 16:00 ET
- 0.613
- 0.0000.00%
Post 20:01 ET
179.01MMarket Cap-0.78P/E (TTM)
0.635High0.598Low2.81MVolume0.625Open0.641Pre Close1.72MTurnover1.30%Turnover RatioLossP/E (Static)292.16MShares3.25652wk High0.34P/B132.67MFloat Cap0.58252wk Low--Dividend TTM216.54MShs Float19.840Historical High--Div YieldTTM5.90%Amplitude0.582Historical Low0.614Avg Price1Lot Size
Lyell Immunopharma Key Stats
Lyell Immunopharma Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Lyell Immunopharma Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data